Article

New ACR Recommendations on Rheumatoid Arthritis Assessment: Why and How

Measuring rheumatoid arthritis symptoms is the focus of new American College of Rheumatology guidelines. An ACR panel member tells how they help assess RA.

(AUDIO) The American College of Rheumatology has issued new recommendations for measuring symptoms and outcomes in rheumatoid arthritis. The six endorsed measures are: The Clinical Disease Activity Index, the Disease Activity Score with 28-joint counts (erythrocyte sedimentation rate or C-reactive protein), the Patient Activity Scale (PAS), PAS-II, the Routine Assessment of Patient Index Data with 3 measures, and the Simplified Disease Activity Index.

Listen as Dr. Salahuddin Kazi, a lead researcher with the guidelines committee, tells why the committee chose these six sets of assessment measures, and how they will help you in managing the condition. Dr. Kazi is Chief Informatics officer and associate professor of medicine in the division of rheumatology at the VA North Texas Healthcare System in Dallas.

The questions:

♦  What mandated guidelines for new measurement standards in RA?
♦  Why six sets of measures? Why not one or two?
♦  How much time will this add to a patient visit? What will be the impact on practice efficiency?
♦  Where can doctors find the recommended measures for rheumatoid arthritis assessment?
♦  What are the remaining areas of uncertainty?

 

ACR's New Recommendations on Rheumatoid Arthritis Assessment: Why and How

 

References:

Standard RA Disease Activity Measures Endorsed by ACRMusculoskeletal Network, April 2, 2012

Rheumatoid Arthritis Disease Activity Measures: American College of Rheumatology Recommendations for Use in Clinical PracticeAmerican College of Rheumatology website

Measure CalculatorsAmerican College of Rheumatology website

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2025 MJH Life Sciences

All rights reserved.